by October Gallery
DUBLIN (Reuters) – A push by makers of electronic cigarettes to raise nicotine levels in the European Union towards their far higher American levels is running into opposition, a senior…
(Reuters Health) – A tiny percentage of people at high risk for opioid overdose are getting prescriptions for naloxone, a medication that could potentially save their lives, a new study…
ATLANTA (Reuters) – U.S. President Donald Trump touted progress in the fight against opioid abuse on Wednesday and promised to hold drugmakers accountable for their part in the crisis, a…
NEW YORK (Reuters) – The U.S. government on Tuesday filed its first criminal charges against a major drug distributor and company executives over their alleged roles in fueling the nation’s…
BOSTON (Reuters) – Insys Therapeutics Inc’s one-time billionaire founder directed a vast scheme to bribe doctors to prescribe an addictive fentanyl spray as opioid addiction was spiraling into a public…
(Reuters Health) – The U.S. government’s toll-free substance abuse helpline, which provides free referral services to those looking for treatment, gets little publicity, a new study finds. By contrast, suicide…
(Reuters Health) – – More than two in five teens who use marijuana experience psychotic symptoms like hallucinations, paranoia and anxiety, a U.S. study suggests. FILE PHOTO: People roll a…
(Reuters Health) – – Not using cannabis for a month could improve learning ability for adolescents and young adults who used the drug at least weekly, a U.S. study suggests.…
(Reuters Health) – Even though there are still a lot of unknowns about the effects of marijuana exposure in the womb and from breast milk, research to date still suggests…
(Reuters Health) – Despite state laws expanding access to the opioid-overdose antidote naloxone without a prescription, two U.S. studies suggest many pharmacies don’t stock the drug or make it easily…